Mounting evidence suggests that synaptic plasticity provides the cellular biological basis of learning and memory, and plasticity deficits play a key role in dementia caused by Alzheimer’s disease. However, the mechanisms by which synaptic dysfunction contributes to the pathogenesis of Alzheimer’s disease remain unclear. In the present study, Alzheimer’s disease transgenic mice were used to determine the relationship between decreased hippocampal synaptic plasticity and pathological changes and cognitive-behavioral deterioration, as well as possible mechanisms underlying decreased synaptic plasticity in the early stages of Alzheimer’s disease-like diseases. APP/PS1 double transgenic (5XFAD; Jackson Laboratory) mice and their littermates (wi...
Alzheimer disease (AD) is a neurodegenerative disorder for which there is no cure. We have investiga...
Abstract. Indirect evidence supports altered glutamate signaling with Alzheimer’s disease, however, ...
Alzheimer’s disease (AD), a neurodegenerative disorder initially characterized by mild memory impai...
The etiology of Alzheimer's disease (AD) remains elusive. The "amyloid" hypothesis states that toxic...
APP.V717I and Tau.P301L transgenic mice develop Alzheimer's disease pathology comprising important a...
We investigated synaptic communication and plasticity in hippocampal slices from mice overexpressing...
Alzheimer's disease (AD) is a highly common neurodegenerative disorder, for which no disease-modifyi...
The synaptic changes underlying the onset of cognitive impairment in Alzheimer’s disease (AD) are po...
International audienceTransgenic mouse models of Alzheimer's disease (AD) that overproduce the amylo...
Transgenic mouse models of Alzheimer's disease (AD) that overproduce the amyloid beta peptide (Aβ) h...
BACKGROUND: Alzheimer disease (AD) is a neurodegenerative disorder for which there is no cure. We ha...
International audienceTransgenic (Tg) mouse models of Alzheimer's disease (AD) are used to investiga...
A form of the amyloid cascade hypothesis proposes that soluble forms of A[Beta] are the initiating f...
In the past years, major efforts have been made to understand the genetics and molecular pathogenesi...
Alzheimer disease (AD) is a neurodegenerative disorder for which there is no cure. We have investiga...
Abstract. Indirect evidence supports altered glutamate signaling with Alzheimer’s disease, however, ...
Alzheimer’s disease (AD), a neurodegenerative disorder initially characterized by mild memory impai...
The etiology of Alzheimer's disease (AD) remains elusive. The "amyloid" hypothesis states that toxic...
APP.V717I and Tau.P301L transgenic mice develop Alzheimer's disease pathology comprising important a...
We investigated synaptic communication and plasticity in hippocampal slices from mice overexpressing...
Alzheimer's disease (AD) is a highly common neurodegenerative disorder, for which no disease-modifyi...
The synaptic changes underlying the onset of cognitive impairment in Alzheimer’s disease (AD) are po...
International audienceTransgenic mouse models of Alzheimer's disease (AD) that overproduce the amylo...
Transgenic mouse models of Alzheimer's disease (AD) that overproduce the amyloid beta peptide (Aβ) h...
BACKGROUND: Alzheimer disease (AD) is a neurodegenerative disorder for which there is no cure. We ha...
International audienceTransgenic (Tg) mouse models of Alzheimer's disease (AD) are used to investiga...
A form of the amyloid cascade hypothesis proposes that soluble forms of A[Beta] are the initiating f...
In the past years, major efforts have been made to understand the genetics and molecular pathogenesi...
Alzheimer disease (AD) is a neurodegenerative disorder for which there is no cure. We have investiga...
Abstract. Indirect evidence supports altered glutamate signaling with Alzheimer’s disease, however, ...
Alzheimer’s disease (AD), a neurodegenerative disorder initially characterized by mild memory impai...